BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 21803185)

  • 21. MIBG in Neuroblastoma Diagnostic Imaging and Therapy.
    Sharp SE; Trout AT; Weiss BD; Gelfand MJ
    Radiographics; 2016; 36(1):258-78. PubMed ID: 26761540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 131I-metaiodobenzylguanidine therapy of neuroblastoma and other neuroendocrine tumors.
    Grünwald F; Ezziddin S
    Semin Nucl Med; 2010 Mar; 40(2):153-63. PubMed ID: 20113683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of advanced neuroblastoma in children over 1 year of age: the critical role of ¹³¹I-metaiodobenzylguanidine combined with chemotherapy in a rapid induction regimen.
    Mastrangelo S; Rufini V; Ruggiero A; Di Giannatale A; Riccardi R
    Pediatr Blood Cancer; 2011 Jul; 56(7):1032-40. PubMed ID: 21344615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimization of molecular radiotherapy with [131I]-meta Iodobenzylguanidine for high-risk neuroblastoma.
    Gaze MN; Gains JE; Walker C; Bomanji JB
    Q J Nucl Med Mol Imaging; 2013 Mar; 57(1):66-78. PubMed ID: 23474636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and efficacy of tandem 131I-metaiodobenzylguanidine infusions in relapsed/refractory neuroblastoma.
    Johnson K; McGlynn B; Saggio J; Baniewicz D; Zhuang H; Maris JM; Mosse YP
    Pediatr Blood Cancer; 2011 Dec; 57(7):1124-9. PubMed ID: 21495159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [131I]metaiodobenzylguanidine therapy after conventional therapy for neuroblastoma.
    Hoefnagel CA; Voûte PA; De Kraker J; Valdés Olmos RA
    J Nucl Biol Med (1991); 1991; 35(4):202-6. PubMed ID: 1823819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-dose
    Kayano D; Wakabayashi H; Nakajima K; Kuroda R; Watanabe S; Inaki A; Toratani A; Akatani N; Yamase T; Kunita Y; Hiromasa T; Takata A; Mori H; Saito S; Araki R; Taki J; Kinuya S
    Ann Nucl Med; 2020 Jun; 34(6):397-406. PubMed ID: 32219730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Dosimetry for therapeutic treatment of neuroblastoma by 131I-mIBG].
    Sudbrock F; Eschner W; Schmidt M; Simon T; Hero B; Schicha H
    Nuklearmedizin; 2006; 45(6):254-61. PubMed ID: 17149494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [131I]MIBG and topotecan: a rationale for combination therapy for neuroblastoma.
    McCluskey AG; Boyd M; Gaze MN; Mairs RJ
    Cancer Lett; 2005 Oct; 228(1-2):221-7. PubMed ID: 15935554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [131I]MIBG as a first line treatment in advanced neuroblastoma.
    Hoefnagel CA; De Kraker J; Valdés Olmos RA; Voûte PA
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):61-4. PubMed ID: 9002752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pretreatment with [131I] metaiodobenzylguanidine and surgical resection of advanced neuroblastoma.
    van Hasselt EJ; Heij HA; de Kraker J; Vos A; Voûte PA
    Eur J Pediatr Surg; 1996 Jun; 6(3):155-8. PubMed ID: 8817208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 131I-MIBG therapy of neural crest tumours (review).
    Troncone L; Rufini V
    Anticancer Res; 1997; 17(3B):1823-31. PubMed ID: 9179240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiolabeled metaiodobenzylguanidine for the treatment of neuroblastoma.
    DuBois SG; Matthay KK
    Nucl Med Biol; 2008 Aug; 35 Suppl 1(Suppl 1):S35-48. PubMed ID: 18707633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A systematic review of 131I-meta iodobenzylguanidine molecular radiotherapy for neuroblastoma.
    Wilson JS; Gains JE; Moroz V; Wheatley K; Gaze MN
    Eur J Cancer; 2014 Mar; 50(4):801-15. PubMed ID: 24333097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe oral mucositis after therapeutic administration of [131I]MIBG in a child with neuroblastoma.
    Dahllöf G; Borgström P; Lundell G; Jacobsson H; Kogner P
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Oct; 92(4):420-3. PubMed ID: 11598577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preoperative [131I]metaiodobenzylguanidine therapy of neuroblastoma at diagnosis ("MIBG de novo").
    Hoefnagel CA; de Kraker J; Voûte PA; Valdés Olmos RA
    J Nucl Biol Med (1991); 1991; 35(4):248-51. PubMed ID: 1823828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of [131I]metaiodobenzylguanidine therapy for patients with refractory neuroblastoma.
    Matthay KK; Huberty JP; Hattner RS; Ablin AR; Engelstad BL; Zoger S; Hasegawa BH; Price D
    J Nucl Biol Med (1991); 1991; 35(4):244-7. PubMed ID: 1823827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Megatherapy combining I(131) metaiodobenzylguanidine and high-dose chemotherapy with haematopoietic progenitor cell rescue for neuroblastoma.
    Miano M; Garaventa A; Pizzitola MR; Piccolo MS; Dallorso S; Villavecchia GP; Bertolazzi C; Cabria M; De Bernardi B
    Bone Marrow Transplant; 2001 Mar; 27(6):571-4. PubMed ID: 11319584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroblastoma therapy using radiolabelled [131I]meta-iodobenzylguanidine ([131I]MIBG) in combination with other agents.
    Mairs RJ
    Eur J Cancer; 1999 Aug; 35(8):1171-3. PubMed ID: 10615225
    [No Abstract]   [Full Text] [Related]  

  • 40. Radiation exposure in nurses during care of
    Taniguchi Y; Wakabayashi H; Inaki A; Kayano D; Yamada M; Kinuya S
    Ann Nucl Med; 2020 Jun; 34(6):441-447. PubMed ID: 32297135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.